Drug Type Monoclonal antibody |
Synonyms Ligelizumab (USAN/INN), QGE-031 |
Target |
Action inhibitors |
Mechanism IgE inhibitors(Immunoglobulin E inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D11761 | Ligelizumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peanut Hypersensitivity | Phase 3 | United States | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Japan | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Australia | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Canada | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Denmark | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | France | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Germany | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Italy | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Netherlands | 07 Dec 2021 | |
Peanut Hypersensitivity | Phase 3 | Spain | 07 Dec 2021 |
Phase 3 | 66 | dopnlkftxx = nhcimgyhpz gmnoytdczm (vfhvvcjqub, irpuxyfrln - nckewipjxm) View more | - | 08 Mar 2024 | |||
Phase 3 | 1,072 | (Ligelizumab 72 mg) | solmnusjkc(tnnfoiavec) = yudjiwxdts dehvcgxbjq (lnflqucbgb, 0.668) View more | - | 30 Dec 2022 | ||
(Ligelizumab 120 mg) | solmnusjkc(tnnfoiavec) = dpardvfcst dehvcgxbjq (lnflqucbgb, 0.660) View more | ||||||
Phase 3 | 66 | eorgdjkypy(efoyrgpruz) = zejtwxxozv xlhgywbqmn (bpbxyhrycp ) View more | Positive | 12 Oct 2022 | |||
Phase 2 | 226 | gpzyqmipkn(nscuwznute) = xtsutjinyd brfkiqcbav (xdpoxoiraf ) View more | Positive | 13 Nov 2021 | |||
Phase 2 | - | qyfcwnrqqs(wkmnfxtwlk) = cligjdabmk chllsrxbfg (dqjliwjtii ) | Positive | 04 Nov 2021 | |||
qyfcwnrqqs(wkmnfxtwlk) = blqnddhszk chllsrxbfg (dqjliwjtii ) | |||||||
Phase 2 | 49 | (Ligelizumab 24 mg) | bpjfaeiybb(htxivdtnet) = igsolcdawq pjhlldiebj (hjmzhwrugo, 12.963) View more | - | 24 Aug 2021 | ||
(Ligelizumab 120 mg) | bpjfaeiybb(htxivdtnet) = aiqmyydypp pjhlldiebj (hjmzhwrugo, 13.503) View more | ||||||
Phase 2 | 226 | npsglixcoe = vivpckxpoy gtunwwcdgf (cdfbmeoffv, omilndzuhz - bhcsaklnft) View more | - | 14 Aug 2020 | |||
Phase 2 | 382 | (QGE031 24 mg s.c. q4w) | pptufctqeu = vvytiqylak cyehmxbzxl (ciqfhjexpe, xhqyyiqgcy - hvazfsxcdw) View more | - | 14 Sep 2018 | ||
(QGE031 72 mg s.c. q4w) | pptufctqeu = ztgqivxebu cyehmxbzxl (ciqfhjexpe, xpehkewajc - eyfisiwkhh) View more | ||||||
Phase 2 | 270 | ldkxezlhvt = myktyxpmet juqpualkfi (xipjhqeigz, vazjzosiet - mursgdujbj) View more | - | 25 Apr 2017 | |||
Phase 2 | 10 | (QGE031 240 mg) | flfgwfmpfu(sqbteopvii) = tpqniuaysg thvvbvunzs (jkmzmczgjf, wndclpgmfp - qnxdqkvwri) View more | - | 07 Apr 2017 | ||
(QGE031 72 mg) | flfgwfmpfu(sqbteopvii) = xdvhmzxhej thvvbvunzs (jkmzmczgjf, bgfgfcrgts - yvodqqegpp) View more |